Article Details

UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis ...

Retrieved on: 2023-01-06 11:04:42

Tags for this article:

Click the tags to see associated articles and topics

UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis .... View article details on HISWAI: https://pipelinereview.com/index.php/2023010682420/Antibodies/UCB-announces-rozanolixizumab-BLA-for-the-treatment-of-generalized-myasthenia-gravis-filed-with-U.S.-FDA-and-designated-for-Priority-Review.html

Excerpt

Details: Category: Antibodies: Published on Friday, 06 January 2023 11:53 ... Rozanolixizumab is a SC administered, humanized monoclonal antibody ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up